The S&P/ASX 200 Index (ASX: XJO) was on form during the 2025 financial year and recorded a gain of approximately 10.2% before dividends.
While this was strong, it pales in comparison to some of the returns that were recorded on the index during the 12 months.
For example, the ASX 200 shares listed below were the best performers with stunning gains for their shareholders. Here's what happened:
Regis Resources Ltd (ASX: RRL)
The Regis Resources share price was the best performer on the ASX 200 in the 2025 financial year with a gain of 150%. Investors were fighting to get hold of Regis Resources shares and other ASX gold miners after a combination of factors helped drive the gold price to record levels. This led to Regis Resources recently posting third-quarter gold sales of $372 million, up 20% on the prior corresponding period despite lower production.
Evolution Mining Ltd (ASX: EVN)
The Evolution Mining share price wasn't far behind with a gain of 128%. It was another gold miner that investors were bidding higher after the gold price surged to a record high. Its recent quarterly update revealed record group mine cash flow and a sizeable cash balance of $661 million.
TechnologyOne Ltd (ASX: TNE)
The TechnologyOne share price was on form and raced 126% higher during the financial year. An impressive performance from the enterprise software provider in FY 2024 and the first half of FY 2025 was largely behind this. In respect to the latter, TechnologyOne reported a 21% jump in annualised recurring revenue (ARR) to $511.1 million. This meant that it achieved its $500 million ARR target 18 months ahead of target. It also upgraded its earnings guidance for the full year.
Zip Co Ltd (ASX: ZIP)
The Zip share price was a strong performer and rose 114% over the 12 months. This buy now pay later provider smashed the market thanks to its incredible performance. In fact, its performance was so strong that management upgraded its guidance twice in FY 2025. Zip's CEO, Cynthia Scott, said: "Zip's momentum has continued throughout May, particularly in the US where TTV has continued to grow above 40% year on year, reflecting the resilience of our business model and disciplined execution of our strategy."
Pro Medicus Ltd (ASX: PME)
The Pro Medicus share price delivered once again for its shareholders, charging 110% over the period. This was driven by further strong earnings growth from the health imaging technology company and the announcement of huge contract wins. One of those was a $330 million 10-year contract with Trinity Health in the United States.
